Document is current
Any future updates will be listed below
-
Authors
de Koster, Elizabeth J. http://orcid.org/0000-0001-8111-1172
Noortman, Wyanne A. http://orcid.org/0000-0003-0450-951X
Mostert, Jacob M. http://orcid.org/0000-0003-1347-411X
Booij, Jan http://orcid.org/0000-0001-6378-7638
Brouwer, Catherine B.
de Keizer, Bart http://orcid.org/0000-0002-6270-9483
de Klerk, John M. H. http://orcid.org/0000-0001-8285-0890
Oyen, Wim J. G. http://orcid.org/0000-0001-8235-7078
van Velden, Floris H. P. http://orcid.org/0000-0003-2859-2119
de Geus-Oei, Lioe-Fee http://orcid.org/0000-0003-1817-2743
Vriens, Dennis http://orcid.org/0000-0001-5762-6766
,
-
Funding
Funding for this research was provided by:
KWF Kankerbestrijding (KUN 2014-6514)
- License Information
-
More Information
Article History
Received: 15 November 2021
Accepted: 26 January 2022
First Online: 9 February 2022
Declarations
:
: The <i>EfFECTS</i> trial protocol was approved by the Medical Research Ethics Committee on Research Involving Human Subjects region Arnhem-Nijmegen, Nijmegen, the Netherlands, on 10 November 2014.
: All patients gave written informed consent prior to any study activities.
: All patients signed informed consent regarding publishing their data.
: The authors declare no competing interests.
